Identification of SURF4 and RALGAPA1 as promising therapeutic targets in glioblastoma and pan-cancer through integrative multi-omics, CRISPR-Cas9 screening and prognostic meta-analysis.
通过整合多组学、CRISPR-Cas9 筛选和预后荟萃分析，确定 SURF4 和 RALGAPA1 为胶质母细胞瘤和泛癌的潜在治疗靶点
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04034-y
Wang Fei, Chen Yuxuan, Huang Run, Lu Dengfeng, Zhang Juyi, Yang Yanbo, Dang Hanhan, Liu Meirong, Chen Zhouqing, Sun Xiaoou, Wang Zhong
